Oncopharmpod

S1801 (Neoadjuvant Pembro In Melanoma)

Informações:

Synopsis

We review a clever study looking at neoadjvuant & adjuvant pembrolizumab vs. only adjuvant pembrolizumab in melanoma. Link: 10.1056/NEJMoa2211437 We also discuss some updates on abemaciclib and osimertinib